Committee MemberEmploymentConsultantSpeakers BureauOwnership/Partnership/PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert WitnessVoting Recusals by Section
Win-Kuang Shen (Chair)Mayo Clinic Arizona—Professor of Medicine; Mayo Clinic College of Medicine—Chair, Department of Cardiovascular DiseasesNoneNoneNoneNoneNoneNoneNone
Robert S. Sheldon (Vice Chair)University of Calgary, Department of Medicine—ProfessorNoneNoneNoneNoneNoneNoneNone
David G. BendittUniversity of Minnesota Medical School, Cardiovascular Division—Professor of Medicine
  • Medtronic

  • St. Jude Medical

NoneNoneNoneNoneNone3.2, 3.2.3, 3.2.5, 4.1.1–4.1.3, 4.2.1–4.2.5, 4.3.1–4.3.5, 5.1–5.3, 10.1, 10.2, 10.3, 10.5, 12
Mitchell I. CohenUniversity of Arizona School of Medicine-Phoenix—Clinical Professor of Child Health; Phoenix Children’s Heart Center—Co-Director; Phoenix Children’s Hospital, Pediatric Cardiology—ChiefNoneNoneNoneNoneNoneNoneNone
Daniel E. FormanUniversity of Pittsburgh—Professor of Medicine; University of Pittsburgh Medical Center—Chair, Geriatric Cardiology Section; VA Pittsburg Healthcare Systems—Director, Cardiac RehabilitationNoneNoneNoneNoneNoneNoneNone
Roy FreemanHarvard Medical School—Professor of Neurology; Beth Israel Deaconess Medical Center, Center for Autonomic and Peripheral Nerve Disorders—Director
  • Lundbeck

NoneNoneNoneNoneNone4.3.1–4.3.5, 5.1, 6.1, 10.1, 10.3, 10.5, 12
Zachary D. GoldbergerUniversity of Washington School of Medicine, Harborview Medical Center Division of Cardiology—Assistant Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Blair P. GrubbUniversity of Toledo Medical Center, Medicine and Pediatrics—Professor
  • Biotronik

  • Medtronic

NoneNoneNoneNoneNone3.2, 3.2.3, 3.2.5, 4.1.1–4.1.3, 4.2.1–4.2.5, 4.3.1–4.3.5, 5.1–5.3, 10.1, 10.2, 10.3, 10.5, 12
Mohamed H. HamdanUniversity of Wisconsin School of Medicine, Cardiovascular Medicine—Professor and Chief of Cardiovascular MedicineNoneNone
  • F2 Solutions

NoneNoneNone2.3.3, 2.3.4, 12
Andrew D. KrahnThe University of British Columbia, Division of Cardiology—Professor of Medicine and Head of Division
  • Medtronic

  • Boston Scientific

  • Medtronic

None3.2, 3.2.3, 3.2.5, 4.1.1–4.1.3, 4.2.1–4.2.5, 4.3.1–4.3.5, 5.1–5.3, 10.1, 10.2, 10.3, 10.5, 12
Mark S. LinkUniversity of Texas Southwestern Medical Center, Department of Medicine, Division of Cardiology—Director, Cardiac Electrophysiology; Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Brian OlshanskyUniversity of Iowa Carver College of Medicine, Cardiovascular Medicine—Emeritus Professor of Internal Medicine; Mercy Hospital North Iowa— Electrophysiologist
  • Lundbeck

Satish R. RajUniversity of Calgary, Cardiac Sciences—Associate Professor
  • GE Healthcare

  • Lundbeck

  • Medtronic

NoneNone2.3.2, 2.3.4, 3.2–3.2.5, 3.3.2, 4.1.1–4.1.3, 4.2.1–4.2.5, 4.3.1–4.3.5, 5.1–5.3, 6.1, 7, 10.1–10.3, 10.5, 12
Roopinder Kaur SandhuUniversity of Alberta, Medical Division of Cardiology—Assistant Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Dan SorajjaMayo Clinic Arizona, Cardiovascular Diseases—Assistant Professor of MedicineNoneNoneNoneNoneNoneNoneNone
Benjamin C. SunOregon Health & Science University—Associate ProfessorNoneNoneNoneNoneNoneNoneNone
Clyde W. YancyNorthwestern University Feinberg School of Medicine, Division of Cardiology—Professor of Medicine and Chief; Diversity & Inclusion—Vice DeanNoneNoneNoneNoneNoneNoneNone

This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.

According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.

ACC indicates American College of Cardiology; AHA, American Heart Association; HRS, Heart Rhythm Society; and VA, Veterans Affairs.

  • Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply (section numbers correspond to the full-text guideline).

  • Significant relationship.

  • Dr. Roy Freeman, the official representative of the American Academy of Neurology, resigned from the writing committee in November 2016, before the final balloting process; recusals noted are from the initial round of balloting. We thank him for his contributions.